Gastroenterology,
In a new clinical trial, researchers determine that Infliximab is not superior to placebo in preventing clinical recurrence…
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection
Overview of attention for article published in Gastroenterology, March 2016
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Mentioned by
- news
- 2 news outlets
- policy
- 2 policy sources
- 38 X users
- 1 Facebook page
- 1 Redditor
- f1000
- 1 research highlight platform
- guideline
- 8 clinical guideline sources
- podcasts
- 1 podcast
Readers on
- mendeley
- 303 Mendeley